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ABSTRACT Cot/tpl2 is the only MAP3K that activates MKK1/2-Erk1/2 in Toll-like receptor–
activated macrophages. Here we show that Cot/tpl2 regulates RSK, S6 ribosomal protein, 
and 4E-BP phosphorylation after stimulation of bone marrow–derived macrophages with li-
popolysaccharide (LPS), poly I:C, or zymosan. The dissociation of the 4E-BP–eIF4E complex, 
a key event in the cap-dependent mRNA translation initiation, is dramatically reduced in LPS-
stimulated Cot/tpl2-knockout (KO) macrophages versus LPS-stimulated wild-type (Wt) mac-
rophages. Accordingly, after LPS activation, increased cap-dependent translation is observed 
in Wt macrophages but not in Cot/tpl2 KO macrophages. In agreement with these data, Cot/
tpl2 increases the polysomal recruitment of the 5´ TOP eEF1α and eEF2 mRNAs, as well as of 
inflammatory mediator gene–encoding mRNAs, such as tumor necrosis factor α (TNFα), inter-
leukin-6 (IL-6), and KC in LPS-stimulated macrophages. In addition, Cot/tpl2 deficiency also 
reduces total TNFα, IL-6, and KC mRNA expression in LPS-stimulated macrophages, which is 
concomitant with a decrease in their mRNA half-lives. Macrophages require rapid fine control 
of translation to provide an accurate and not self-damaging response to host infection, and 
our data show that Cot/tpl2 controls inflammatory mediator gene–encoding mRNA transla-
tion in Toll-like receptor–activated macrophages.
INTRODUCTION
Translational control of gene expression is an important regulatory 
step in which the amount of protein to be produced of an already 
transcribed mRNA is modulated. Translation of mRNAs is subject to 
tight control by cells, providing a rapid and adequate response to 
external cell stimuli. In addition, cells have also developed mecha-
nisms to control the stability of mRNAs (Chen and Shyu, 1995; 
Anderson, 2008; Guo et al., 2010). A key limiting step of translation 
is the initiation step, during which the small ribosome subunit is 
recruited to the 5´ untranslated region (UTR) of the cap-mRNA 
and scans toward the start codon (reviewed in Gingras et al., 1999; 
Sachs and Varani, 2000; Hellen and Sarnow, 2001). In certain tran-
scripts and under defined conditions, the cap is bypassed by use of 
an internal ribosome entry site (IRES), which is located in the 5´UTR 
of transcripts (Pestova et al., 2001).
Cap-dependent translation is facilitated by the recognition of the 
mRNA 5´m7GpppN cap structure by eIF4F, which includes the cap-
binding subunit, eIF4E. The assembly of the active eIF4F is blocked 
by the reversible association of eIF4E with the translation repressors 
4E-binding proteins (4E-BPs), in which the release of 4E-BP is the 
key event in the control of cap-dependent mRNA translation initia-
tion. Dissociation of the eIF4E–4E-BP complex is achieved by 4E-BP 
phosphorylation, controlled by the mammalian/mechanistic target 
of rapamycin complex 1 (mTORC1; reviewed in Gingras et al., 1999; 
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critical role in the production of tumor necrosis factor α (TNFα) dur-
ing inflammatory responses; it regulates the processing of the pre-
TNFα protein before its secretion (Rousseau et al., 2008), modulates 
the nuclear export of TNFα mRNA (Dumitru et al., 2000), and also 
enhances TNFα gene transcription (Ballester et al., 1998).
In the context of innate immunity, and in addition to the con-
trolled transcriptional activation, the control at the level of transla-
tion of cytokine and chemokine mRNAs plays an essential role in the 
required rapid and accurate response against infection without 
damage of the host cells (reviewed in Anderson, 2008, 2010; Hao 
and Baltimore, 2009).
Here we show that Cot/tpl2 controls mTORC1-dependent mRNA 
translation in TLR-activated macrophages. Cot/tpl2, via Erk1/2, reg-
ulates the dissociation of the 4E-BP–eIF4E complex and the mRNA 
polysomal recruitment of 5´TOP mRNAs. Cot/tpl2 also controls the 
recruitment onto translating polysomes of mRNAs that encode pro-
teins involved in the innate immune response such as TNFα, IL-6, 
and KC. In addition, Cot/tpl2 also increases the half-life of these 
mRNAs, affecting their total mRNA expression levels.
RESULTS
Cot/tpl2 controls, in an Erk1/2-dependent manner, 
4E-BP1 phosphorylation in TLR-stimulated macrophages
Cot/tpl2 mediates Erk1/2 activation in the macrophagic cell line 
RAW, peritoneal macrophages, and bone marrow–derived mac-
rophages (BMDM) upon engagement of lipopolysaccharide (LPS) to 
TLR4 (Dumitru et al., 2000; Caivano et al., 2003; Figure 1A). Subse-
quently, activated Cot/tpl2 is rapidly degraded through the protea-
some pathway (Gandara et al., 2003; Waterfield et al., 2003). In addi-
tion, in LPS-activated BMDM, Cot/tpl2 controls the phosphorylation 
of Akt on S473 (Lopez-Pelaez et al., 2011; Figure 1A), a residue phos-
phorylated by mTORC2 (Sarbassov et al., 2005). The phosphoryla-
tion of SGK1 on S422, which is also dependent on mTORC2 activity 
(Garcia-Martinez and Alessi, 2008), was also diminished in LPS-stim-
ulated Cot/tpl2-knockout (KO) BMDM compared with LPS-stimu-
lated wild-type (Wt) BMDM (Figure 1A). However, the loss of Cot/
tpl2 expression did not affect the phosphorylation of T308 in the 
activation loop of Akt by PDK1. These data indicate that Cot/tpl2 
deficiency does not affect the activation of PDK1 by PI3K in LPS-
treated macrophages but suggest deficient mTORC2 activation in 
LPS-treated Cot/tpl2 KO BMDM versus their Wt counterparts. Akt 
needs to be phosphorylated on both residues S473 and T308 to be 
fully active and to phosphorylate FOXO1 on T24; however, phospho-
rylation of Akt on T308 is sufficient to phosphorylate TSC2 on S939 
(Guertin et al., 2006). Accordingly, T24 FOXO1 phosphorylation was 
clearly reduced in Cot/tpl2 KO BMDM versus Wt BMDM upon LPS 
stimulation, whereas S939 TSC2 phosphorylation was only slightly 
reduced, just by 20% after 90 min of LPS stimulation (Figure 1A).
Compared to their Wt counterparts, LPS-stimulated Cot/tpl2 KO 
BMDM showed a statistically significant reduction of T573 RSK 
phosphorylation (Figure 1B), explaining the reduced phosphoryla-
tion in the same setting of its substrate TSC2 in residue S1798 and 
of the downstream effectors S6K1, S6, and eEF2k (Figure 1B). The 
phosphorylation of 4E-BP by mTORC1 is the key signal that triggers 
the dissociation of eIF4E from the inactive 4E-BP–eIF4E complex, 
allowing eIF4E to form the active eIF4F complex. Active eIF4F facili-
tates the initiation of translation by its binding to the m7GpppN cap 
site located at the 5′-terminus of all mRNAs (Gingras et al., 1999; 
Pestova et al., 2001). Decreased phosphorylation of 4E-BP1 in Cot/
tpl2 KO BMDM versus their Wt counterparts was already observed 
in basal conditions, and upon LPS stimulation, the difference in the 
4E-BP1 phosphorylation ratio was further increased by Cot/tpl2 
Pestova et al., 2001). However, cap-dependent translation of differ-
ent mRNAs is not equally sensitive to mTORC1 activity, with 5´TOP 
mRNAs, as well as mRNAs with highly structured 5´UTR, being very 
sensitive to mTORC1 activity (Topisirovic et al., 2011; Huo et al., 
2012; Thoreen et al., 2012). mTORC1 also phosphorylates/activates 
S6K1 (p70 S6k), which is responsible for the phosphorylation of the 
ribosomal protein S6. S6K1 also upregulates peptide elongation by 
phosphorylating and consequently inhibiting elongation factor 2 ki-
nase (eEF2k), which phosphorylates and represses eEF2 (Wang 
et al., 2001). PI3K signaling connected via Akt, by direct phosphory-
lation of TSC2, can block the TSC1/TSC2 complex inhibitory action 
on mTORC1 activity (reviewed in Gingras et al., 1999; Sachs and 
Varani, 2000; Hellen and Sarnow, 2001). Indeed, the PI3K intracel-
lular pathway controls mRNA translation (Laplante and Sabatini, 
2009), including the translation of 5´TOP mRNAs, which contain a 
5′-terminal oligopyrimidine tract (5′TOP) and encode components 
of the translational machinery (Jefferies et al., 1997; Meyuhas, 2000; 
Tang et al., 2001; Patursky-Polischuk et al., 2009). On the other 
hand, the activity of mTORC1 and of its downstream effectors is also 
enhanced by the kinase RSK (Anjum and Blenis, 2008; Pearce et al., 
2010). Activation of the RAS-RAF-MKK1/2-Erk1/2 pathway triggers 
RSK phosphorylation/activation, which subsequently phosphory-
lates TSC2 (Roux et al., 2004). RSK also phosphorylates the subunit 
of mTORC1, Raptor (Carriere et al., 2008), and S6 (Roux et al., 2007), 
as well as eEF2k (Bain et al., 2007). Indeed, both RAF and PI3K path-
ways stimulate mTORC1 signaling (Anjum and Blenis, 2008; Pearce 
et al., 2010).
Activation of PI3K occurs by a broad array of different stimuli in a 
variety of different cell types. In innate immune cells such as mac-
rophages, PI3K activation, among other intracellular signaling path-
ways, occurs upon activation of different Toll-like receptors (TLRs; 
reviewed in Fukao and Koyasu, 2003; Chaurasia et al., 2010). Recep-
tors of this family sense infection and are stimulated by different 
pathogen-associated molecular patterns. Activation of the different 
intracellular pathways upon TLRs stimulation orchestrates the first 
line of resistance against infection, triggering the production of cy-
tokines and chemokines critical for host defense (Kawai and Akira, 
2011). All TLRs, except TLR3, recruit the adaptor MyD88, which trans-
duces the intracellular signal to activate the kinase TAK1. Conse-
quently, TAK1 activates the p38α and JNK MAP kinase pathways, as 
well as the canonical IKKs, IKKα and IKKβ. TLR3 and TLR4 recruit the 
TRIF adaptor, which specifically activates the noncanonical IKKs but 
also IKKα and IKKβ (reviewed in Akira and Takeda, 2004; O’Neill and 
Bowie, 2007). Activated IKKβ phosphorylates IκB and p105 NF-κB, 
targeting IκB to degradation and p105 NF-κB to partial proteolysis. 
In resting cells, Cot/tpl2 (MAP3K8) forms a stable and inactive com-
plex with p105 NF-κB and ABIN2, protecting Cot/tpl2 from its deg-
radation. The partial proteolysis of p105 NF-κB to p50 NF-κB re-
leases Cot/tpl2 from the complex (reviewed in Gantke et al., 2011; 
Vougioukalaki et al., 2011). On TLR stimulation, dissociated Cot/tpl2 
with an adequate phosphorylation state fully activates MKK1/2 and 
consequently Erk1/2 (Dumitru et al., 2000; Caivano et al., 2003; Cho 
and Tsichlis, 2005; Banerjee et al., 2006; Stafford et al., 2006) before 
being rapidly degraded through the proteasome pathway (Gandara 
et al., 2003; Waterfield et al., 2003). Cot/tpl2 is the only MAP3K that 
activates the Erk1/2 pathway under these cell stimulation conditions 
and fulfils a role in innate immunity and inflammatory hypernocicep-
tion that cannot be substituted for by any other protein (Cohen, 
2009; Soria-Castro et al., 2010; Gantke et al., 2011; Vougioukalaki 
et al., 2011). Cot/tpl2 participates in the production of interleukin-1β 
and represses interferon-β transcription (Kaiser et al., 2009; Mielke 
et al., 2009; Lopez-Pelaez et al., 2011). In addition, Cot/tpl2 has a 
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deficiency (Figure 1C). Of note, total 4E-BP1 
expression levels were very similar in both 
Wt and Cot/tpl2 KO BMDM. On the other 
hand, the phosphorylation of eIF4E on S209 
by MNK, a p38α- and Erk1/2-dependent ki-
nase (Marzec et al., 2011), was also dimin-
ished by Cot/tpl2 deficiency in LPS-stimu-
lated BMDM.
To examine whether the observed im-
paired phosphorylation of proteins involved 
in the initiation of the cap-dependent mRNA 
translation by Cot/tpl2 deficiency was just 
due to the lack of Cot/tpl2 activity or to the 
knockout of Cot/tpl2 protein expression, we 
used Cot/tpl2 kinase-dead (KD) BMDMs, 
which express Cot/tpl2 with a point muta-
tion in which the lysine responsible for ATP 
binding (Lys-167) is replaced by Arg and 
thereby does not have kinase activity. In-
deed, the Cot/tpl2 catalytically inactive pro-
tein was not degraded after LPS stimulation, 
indicating that Cot/tpl2 activity participates 
in a negative feedback loop ending in its 
own degradation (Figure 2A). Because 
S235/236 S6 and S366 eEF2k phosphoryla-
tion, as well as the phosphorylation S65 4E-
BP1 and S209 eIF4E was also diminished 
in LPS-stimulated Cot/tpl2 KD BMDM as 
compared with their Wt counterparts (Figure 
2A), we conclude that is just the activity of 
Cot/tpl2 that is essential in the activation of 
proteins involved in the cap-dependent 
mRNA translation. In addition, LPS-stimu-
lated Wt BMDM preincubated with PD 
0325901, a specific MKK1/2 inhibitor (Bain 
et al., 2007), also showed impaired phos-
phorylation of S6, eEF2k, eIF4E, and 4E-BP1 
compared with Wt BMDM after LPS stimula-
tion in the absence of the inhibitor (Figure 
2B). Furthermore, pretreatment with UO126, 
another MKK1/2 inhibitor, or with rapamy-
cin, an inhibitor of mTORC1 activity, also 
reduced the phosphorylation state of 4E-
BP1 in LPS-stimulated Wt BMDM (Figure 
2C). Taken together, these data indicate that 
the capacity of Cot/tpl2 to control Erk1/2 
phosphorylation in LPS-activated BMDM is 
essential for the modulation of the phos-
phorylation/activation state of proteins in-
volved in the mRNA translation process in 
LPS-activated macrophages.
LPS signals through both TRIF and 
MyD88 adaptors after TLR4 activation 
(Akira and Takeda, 2004; O’Neill and 
Bowie, 2007). In macrophages with low lev-
els of the receptor dectin-1, zymosan stim-
ulates TLR2/6 and signals through the 
MyD88 adaptor (Gantner et al., 2003), 
whereas poly I:C activates TLR3, a receptor 
that is incapable of recruiting MyD88 and 
signals through TRIF (O’Neill and Bowie, 
FIGURE 1: Cot/tpl2 governs the phosphorylation state of proteins involved in cap-dependent 
translation in LPS-stimulated BMDM. (A) Wt and Cot/tpl2 KO BMDM were stimulated with LPS 
(300 ng/ml), and after the indicated times Cot/tpl2, P-Erk1/2, P-T308 Akt, P-S473 Akt, P-S422 
SGK1, P-T24 FOXO1, and P-S939 TSC2 levels were measured by Western blot. Erk2, Akt, SGK1, 
FOXO1, TSC2, and β-actin levels were determined as a protein loading control. Right, graphs 
represent the means ± SD from five independent experiments of P-T24 FOXO1 and P-S939 
TSC2 fold induction relative to the Wt zero time point, after normalizing values to, respectively, 
total FOXO1 and total TSC2. (B) Cell extracts obtained as described in A were subjected to 
Western blot analysis using antibodies against the following phosphoproteins: P-T573 RSK, 
P-S1798 TSC2, P-T389 S6K1, P-S235/236 S6, and P-S366 eEF2k.The antibodies against total 
proteins used were RSK, TSC2, S6K1, S6, eEF2k, Erk2, and β-actin. The graphs represent the 
means ± SD from at least four independent experiments of P-T573 RSK, P-S1798 TSC2, 
P-S235/236 S6, and P-S366 eEF2k fold induction relative to the Wt zero time point, after 
normalizing values to, respectively, total RSK, TSC2, S6, and eEF2k. (C) Western blots of cell 
extracts obtained as described in A were probed against P-S65 4E-BP1, P-S209 eIF4E, 4E-BP1, 
eIF4E, and β-actin. Right, graphs represent the means ± SD from five independent experiments 
of P-S65 4E-BP1 and P-S209 eIF4E fold induction relative to the Wt zero time point, after 
normalizing values to, respectively, total 4E-BP1 and total eIF4E (A, B). Quantification of the 
induction fold of P-Erk1/2, P-T308 Akt, P-S473 Akt, P-S422 SGK1, and P-T389 S6K1 levels is 
shown in Supplemental Table S1.
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to eIF4E decreased in a statistically signifi-
cant manner upon LPS stimulation of Wt 
BMDM, but the absence of Cot/tpl2 expres-
sion severely affected the release of 4E-BP1 
from the 4E-BP1–eIF4E complex in LPS-
stimulated BMDM (Figure 4A). These data 
prompted us to study the cap-dependent 
and cap-independent translation rates in 
LPS-stimulated Wt and Cot/tpl2 KO BMDM. 
To this end, cells were nucleofected with a 
biscitronic plasmid in which Renilla luciferase 
cDNA can be only translated by cap-depen-
dent scanning mechanism, whereas transla-
tion of Firefly luciferase does not happen 
unless internal initiation occurs at the IRES 
element (Figure 4B). Similar levels of cap-
independent translation were observed in 
Wt and Cot/tpl2 KO BMDM stimulated or 
not with LPS. Nevertheless, cap-dependent 
translation was increased in Wt BMDM com-
pared with Cot/tpl2 KO BMDM in basal con-
ditions, and, as expected, LPS stimulation of 
Wt BMDM further increased cap-dependent 
translation in a statistically significant man-
ner . However, this increase was hardly de-
tected in Cot/tpl2 KO BMDM after LPS 
stimulation, resulting in a statistically signifi-
cant increase in the cap-dependent/cap-
independent translation ratio in Wt BMDM 
versus Cot/tpl2 KO BMDM (Figure 4B).
Cot/tpl2 controls the translation of the 
5´TOP eEF1α and eEF2 mRNAs
BMDM from Wt and Cot/tpl2 KO mice were 
treated or not with LPS for 3 h, and sucrose 
gradient was performed to separate non-
polysomal mRNAs and nontranslating free 
40S and 60S ribosomal subunits from mod-
erately and from actively translating mRNA 
polysomes. The nonpolysomal fraction (NP) 
contained the pool of mRNAs that were not 
associated with components of the transla-
tion machinery or cosedimented with ribosome subunits (mono-
somes); thus, they were not considered to be translated. The mRNAs 
contained in the fraction with small polysomes of low molecular 
weight (LMP) were considered to be translated at moderate levels. 
The third mRNA fraction contained mRNAs that were associated 
with polysomes of high molecular weight (HMP), and they were thus 
considered to be actively translated (Supplemental Figure S2). On 
3 h of LPS stimulation of Wt and Cot/tpl2 KO BMDM, there was an 
increase in the recruitment of the 5´TOP eEF1α mRNA to HMP in 
detriment to the levels detected in the inactive pool. However, the 
increase in the recruitment of eEF1α mRNA on the actively translat-
ing polysomes was, in a statistically significant way, lower in Cot/tpl2 
KO BMDM versus Wt BMDM, as determined by Northern blot anal-
ysis. By contrast, β-actin mRNA, which is known to be constitutively 
translated, was associated mostly with the HMP fraction in stimu-
lated and nonstimulated cells and irrespective of their genotype 
(Figure 5A). Similar reduction in the eEF1α mRNA polysomal recruit-
ment was observed in LPS-stimulated Wt BMDM in the presence of 
UO126 compared with Wt BMDM stimulated with LPS in the ab-
sence of this inhibitor (Supplemental Figure S3). According to these 
2007). Results obtained in Wt and Cot/tpl2 KO BMDM stimulated 
with poly I:C or with zymosan and analyzed by Western blot indi-
cated that RSK, eIF4E, eEF2k, S6, and S65 4E-BP1 phosphoryla-
tion was also controlled by Cot/tpl2 under these cell stimulation 
conditions (Figure 3). However, Wt and Cot/tpl2 KO BMDM 
showed similar levels of S65 4E-BP phosphorylation after 15 and 
30 min of stimulation with IL-10 (Supplemental Figure S1).
Cot/tpl2 regulates cap-dependent translation 
in LPS-activated macrophages
We next decided to evaluate whether the reduced 4E-BP1 phos-
phorylation observed by Cot/tpl2 deficiency in TLR-activated BMDM 
correlated with a diminished dissociation of the 4E-BP1–eIF4E com-
plex. To this end, extracts from Wt and Cot/tpl2 KO BMDM non-
treated or treated for 1 or 2 h with LPS were incubated with the 
m7GpppN cap affinity resin, and the levels pulled-down of eIF4E 
and 4E-BP1 proteins were subsequently determined by Western 
blot analysis (Figure 4A). In basal conditions, Cot/tpl2 KO BMDM 
already showed increased levels of 4E-BP1 bound to eIF4E com-
pared with Wt BMDM. Furthermore, the amount of 4E-BP1 bound 
FIGURE 2: Erk1/2-dependent phosphorylation of P-S235/236 S6, P-S366 eEF2k, P-S65 4E-BP1, 
and P-S209 eIF4E in LPS-stimulated BMDM. (A) Wt and Cot/tpl2 KD BMDM were stimulated for 
different lengths of time with LPS (300 ng/ml), and the extracts obtained were analyzed by 
Western blots probed with the phospho antibodies against P-Erk1/2, P-S235/236 S6, P-S366 
eEF2k, and P-S65 4E-BP1 and with antibodies against the total protein of Cot/tpl2, Erk2, S6, 
eEF2k, 4E-BP1, and eIF4E as loading controls. (B) Wt BMDMs were preincubated or not with the 
MKK1/2 inhibitor PD 0325901 (0.5 μM) for 60 min before stimulation with LPS (300 ng/ml) for the 
indicated times, after which the levels of P-Erk1/2, P-S235/236 S6, P-S366 eEF2k, P-S65 4E-BP1, 
and P-S209 eIF4E were determined by Western blot analysis. As a loading control, membranes 
were also blotted with the following antibodies: Erk2, S6, eEF2k, 4E-BP1, and eIF4E. (C) Wt 
BMDM were preincubated or not with the MKK1/2 inhibitor UO 126 (10 μM) or rapamycin (20 
nM) for 60 min before stimulation with LPS (300 ng/ml) for the indicated times, after which the 
levels of P-Erk1/2, P-S65 4E-BP1, Erk2, and 4E-BP1 were determined by Western blot analysis. 
Graph represents the means ± SD from three independent experiments of P-S65 4E-BP1 fold 
induction relative to the Wt zero time point, after normalizing values to total 4E-BP1. For A–C, 
one representative experiment of the three independently performed is shown.
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data, Cot/tpl2 deficiency also impaired eEF1α 
mRNA distribution within polysomal versus non-
polysomal RNA fractions (Supplemental Figure 
S2) as performed by quantitative real-time PCR 
(qRT-PCR) analysis (Figure 5B), and again no 
change in the β-actin distribution was observed 
in these analysis conditions. To determine 
whether the effects of Cot/tpl2 were unique for 
the EF1α mRNA or could be extended to other 
5´TOP mRNAs, we also analyzed the recruitment 
onto polysomes of another 5´TOP mRNA, the 
eEF2 mRNA. In LPS-activated Wt BMDM this 
transcript was mainly located in the translated 
mRNA fraction, but under the same conditions 
Cot/tpl2 deficiency mainly abolished eEF2 mRNA 
polysomal recruitment upon LPS stimulation 
(Figure 5B). Of note, similar levels of total eEF1α, 
eEF2, or β-actin mRNA were detected in Wt and 
Cot/tpl2 KO BMDM stimulated or not with LPS 
(Supplemental Figure S4).
Cot/tpl2 modulates polysomal recruitment 
of TNFα, IL-6, and KC mRNA in 
LPS-activated BMDM
We previously showed that in LPS-activated mac-
rophages Cot/tpl2 deficiency triggered a fivefold 
increase in the IRF1 mRNA levels but only ap-
proximately twofold in the IRF1 protein levels 
respect to Wt BMDM in the same cell conditions 
(Lopez-Pelaez et al., 2011). The polysomal mRNA 
distribution of this transcription factor, involved 
in macrophage activation (reviewed in Tamura 
et al., 2008), indicated that Cot/tpl2 expression is 
required to increase the recruitment of IRF1 
mRNA to polysomes upon LPS stimulation of 
BMDM (Supplemental Figure S5). Furthermore, 
the recovery of IκBα protein levels after TNFα 
stimulation of mouse embryonic fibroblasts (Das 
et al., 2005) or upon LPS stimulation of BMDM 
(Lopez-Pelaez et al., 2011) is diminished in the 
absence of Cot/tpl2. The similar expression lev-
els of IκBα mRNA after LPS stimulation of Wt and 
Cot/tpl2 KO BMDM (Supplemental Figure S5) 
could not explain the previously reported im-
paired IκBα protein expression; however, Cot/
tpl2 deficiency reduced IκBα mRNA levels in the 
polysomes fraction upon 3 h of LPS stimulation 
(Supplemental Figure S5), arguing that Cot/tpl2 
stimulates the translation of IκBα mRNA. Of in-
terest, IκBβ showed similar protein expression 
levels in Wt and Cot/tpl2 KO BMDM after LPS 
stimulation (unpublished data), and Cot/tpl2 did 
not appear to regulate IκBβ mRNA recruitment 
to polysomes (Supplemental Figure S5).
Cot/tpl2 controls TNFα production in LPS-
activated macrophages (Dumitru et al., 2000; 
Rousseau et al., 2008; Figure 6A). In addition, an 
analysis of the TNFα mRNA distribution within 
the polysomal and nonpolysomal RNA fractions 
upon LPS stimulation of Wt and Cot/tpl2 KO 
BMDM indicated that Cot/tpl2 increased TNFα 
mRNA polysomal recruitment (Figure 6B). 
FIGURE 3: P-S65 4E-BP1 phosphorylation in Wt and Cot/tpl2 KO BMDM stimulated with 
zymosan or poly I:C. Wt and Cot/tpl2 KO BMDM were stimulated with zymosan (10 μg/ml; 
A) or with poly I:C (50 μg/ml; B) for 30 and 60 min and the expression levels of P-Erk1/2, 
P-T573 RSK, P-S209 eIF4E, P-S366 eEF2k, P-S235/236 S6, and P-S65 4E-BP1 were 
determined in Western blots. As a loading control the expression levels of Erk2, eIF4E, S6, 
and 4E-BP1 were also analyzed. For both A and B, one representative experiment of the 
three independently performed is shown. Right, graphs represent the means ± SD from five 
independent experiments of P-S209 eIF4E, eEF2k, P-S235/236 S6, and P-S65 4E-BP1 fold 
induction relative to the Wt zero time point, after normalizing values to, respectively, total 
eIF4E, Erk2, S6, and 4E-BP1.
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Furthermore, Cot/tpl2 deficiency diminished the levels of other two 
inflammatory mediators, IL-6 and KC, in the incubation media of 
BMDM upon LPS stimulation (Figure 6A), and LPS-stimulated Cot/
tpl2 KO BMDM showed a severely diminished recruitment of IL-6 
and KC mRNAs to polysomes compared with their Wt counterparts 
(Figure 6B).
Cot/tpl2 increases TNFα, IL-6, and KC mRNA stability 
in LPS-activated BMDM
In addition to the reduced recruitment of TNFα, KC, and IL-6 mRNA 
to polysomes, Cot/tpl2 deficiency also reduced total mRNA levels 
of TNFα, KC, and IL-6 ∼3-, 2.5-, and 6.5-fold, respectively, in 3 h 
LPS-stimulated BMDM (Figure 7A). To determine whether Cot/tpl2 
enhances the stability of these mRNAs, Wt and Cot/tpl2 KO BMDM 
were first treated with LPS for 3 h to induce their expression, and 
subsequently, to block transcription, actinomycin D was added to 
the cell culture media and the decay in the expression levels of 
TNFα, KC, and IL-6 mRNA was examined. In LPS-stimulated BMDM, 
Cot/tpl2 stabilizes TNFα, KC, and IL-6 mRNA, with an increase in 
the half-life of ∼2.5-fold for TNFα and IL-6 mRNA and ∼5-fold for the 
KC transcript (Figure 7B), indicating that the increase in the total 
mRNA levels of these cytokines and chemokine by Cot/tpl2 after 
LPS stimulation could be mainly due to a stabilization of their mR-
NAs. Of note, the half-life of β-actin mRNA was not affected by Cot/
tpl2 deficiency. Taken together, these data indicate that Cot/tpl2 not 
only controls the translation of inflammatory mediator gene–encod-
ing mRNAs but also controls the mRNA stability of cytokine and 
chemokine transcripts in the context of the innate immune response 
generated upon LPS stimulation of macrophages.
DISCUSSION
Cot/tpl2 has emerged as an attractive target to develop new and 
improved anti-inflammatory drugs (Cohen, 2009; Gaestel et al., 2009) 
since it plays a role after TLR activation of macrophages that affects 
the innate immune response (reviewed in Gantke et al., 2011). Here 
we show a novel function for Cot/tpl2 in controlling the activation 
state of proteins involved in cap-dependent translation initiation. The 
PI3K-Akt-TSC2-mTORC1 pathway plays, through their downstream 
effectors, a key role in the maintenance of translation (Laplante and 
Sabatini, 2009). However, the fact that in TLR-activated macrophages 
Cot/tpl2 deficiency does not alter the phosphorylation of Akt on 
T308 but only on S473 indicates that Cot/tpl2 does not modulate 
4E-BP phosphorylation through Akt, since the partial activation of 
Akt, P-T308 Akt, by PI3K-PDK1 upon TLR stimulation is sufficient to 
transduce the activating signal to TSC2 (Guertin et al., 2006). On the 
other hand, the RAS-RAF-MKK1/2-Erk1/2 pathway, by activating the 
Erk1/2-dependent kinase RSK, also triggers mTORC1 activation (re-
viewed in Anjum and Blenis, 2008; Pearce et al., 2010). Stimulation of 
the receptors of the TLR/IL-1R superfamily does not activate any of 
the RAF proteins, and the activation of the MKK1/2-Erk1/2 pathway 
is entirely mediated by Cot/tpl2 (Caivano et al., 2003; Cho and 
Tsichlis, 2005; Banerjee et al., 2006; Rodriguez et al., 2006; Gantke 
et al., 2011). On the basis of the data shown here, and taking into 
account the mechanism by which Cot/tpl2 is activated (Rodriguez 
et al., 2006; Gantke et al., 2011; Vougioukalaki et al., 2011), we can 
conclude that after TLR activation the TAK1-IKKβ-Cot/tpl2-MKK1/2-
Erk1/2 pathway also has RSK as a downstream effector. In addition, 
Cot/tpl2-dependent activation of RSK links Cot/tpl2, via Erk1/2, with 
the capacity to control cap-dependent mRNA translation initiation, 
the key rate-limiting step in the translation process. Nevertheless, 
we cannot rule out the possibility that Cot/tpl2-MKK1/2-Erk1/2 also 
inhibits the TSC1-TSC2 complex and consequently increases 
FIGURE 4: Cot/tpl2 promotes dissociation of the 4E-BP1–eIF4E 
complex and cap-dependent translation. (A) Cell extracts from Wt 
and Cot/tpl2 KO BMDM stimulated or not for 1 or 2 h with LPS 
(300 ng/ml) were subjected to m7GTP–Sepharose bead pull-down 
assays, and the amount of 4E-BP1 bound to eIF4E was analyzed by 
Western blot. Expression levels of P-S65 4E-BP1, 4E-BP1, eIF4E, and 
Erk2 in total cell extracts are also shown. Representative experiments 
of the three independently performed are shown. Graph represents 
the means ± SD from three independent experiments of the 4E-BP1/
eIF4E values, giving the value of 1 to the one obtained in Wt BMDM 
at zero point time. (B) Wt and Cot/tpl2 KO BMDM were nucleofected 
as indicated in Materials and Methods, with the biscitronic plasmid 
specified in the figure. Cells were harvested, and Renilla and Firefly 
luciferase luminescence was quantified using a luminometer. Graph 
represents the means ± SD from three independent experiments of 
Renilla/firefly luciferase values, giving the value of 1 to the one 
obtained in Wt BMDM at zero time point.
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to the m7GpppN located in the 5′ region of 
most mRNA sequences (Gingras et al., 1999; 
Pestova et al., 2001). Accordingly, with the 
deficient 4E-BP1 phosphorylation in LPS-
stimulated Cot/tpl2 KO BMDM versus Wt 
BMDM, Cot/tpl2 deficiency also prevents in 
a statistically significant manner the dissoci-
ation of the eIF4E–4E-BP complex and di-
minishes translation of the cap-dependent 
Renilla luciferase. Taken together, these data 
indicate that Cot/tpl2 controls the activation 
of the cap–dependent translational machin-
ery in TLR-activated macrophages. Accord-
ingly, mRNA recruitment to polysomes of 
transcripts encoding proteins that are in-
volved in the innate immune response, such 
as TNFα, IL-6, and KC, is severely dimin-
ished by Cot/tpl2 deficiency.
This newly described capacity of Cot/
tpl2 to control the activation state of pro-
teins involved in the mRNA translation pro-
cess occurs independent of the type of 
adaptor, MyD88 or TRIF, used by TLRs to 
transduce the activating signals since it is 
observed upon both poly I:C and zymosan 
stimulation of macrophages. Nevertheless, 
this capacity of Cot/tpl2 is so far a selective 
and specific event triggered by TLR activa-
tion, since Cot/tpl2 has no effect on 4E-BP 
phosphorylation in BMDM stimulated with 
IL-10, which uses a receptor distinct from 
the TLR family (Kotenko et al., 1997), and 
does not activates Cot/tpl2 (Lopez-Pelaez 
et al., 2011). In this context, it was recently 
reported that Cot/tpl2 is also the only 
MAP3K that activates Erk1/2 in signals initi-
ated by the thrombin-activated, G protein–
coupled, receptor protease–activated re-
ceptor-1 (Hatziapostolou et al., 2011); thus 
the possibility that Cot/tpl2 could control 
cap-dependent translation initiation in other 
biological processes cannot be excluded.
Here we also describe that Cot/tpl2 reg-
ulates the translation of the 5´TOP mRNAs 
eEF1α and eEF2. The 5´TOP mRNAs con-
tain a 5′-terminal oligopyrimidine tract and 
encode ribosomal proteins involved in the 
processing of mRNA, and their translation is 
very sensitive to mTORC1 activity (Jefferies 
et al., 1997; Meyuhas, 2000; Tang et al., 2001; Patursky-Polischuk 
et al., 2009; Thoreen et al., 2012). In this context, it has been shown 
that sensitivity of mRNA translation to mTORC1 activation varies 
depending on the mRNA species (Topisirovic et al., 2011; Huo et al., 
2012; Thoreen et al., 2012). Indeed, β-actin mRNA translation is 
barely dependent on mTORC1 activation and 4E-BP1 phosphoryla-
tion (Colina et al., 2008; Huo et al., 2012; Thoreen et al., 2012), and 
our data here show that Cot/tpl2 modulates the downstream effec-
tors of mTORC1 but not polysomal recruitment of β-actin.
Not only does Cot/tpl2 modulate TNFα, KC, and IL-6 mRNA 
polysomal recruitment in activated macrophages, but it also partici-
pates in the expression of their total mRNA levels upon LPS stimula-
tion of macrophages. Total mRNA levels are the result of both the 
mTORC1 activity by Erk1/2 direct phosphorylation of TSC2 on S664 
(Ma et al., 2005). These data indicate a novel role of Cot/tpl2 in mod-
ulating the now evident important role that mTORC1 substrates have 
in innate immunity development (reviewed in Thomson et al., 2009; 
Weichhart and Saemann, 2009).
4E-BP phosphorylation by mTORC1 is the key event in the regu-
lation of cap-dependent translation. Here we show that Cot/tpl2-
MKK1/2-Erk1/2 triggers 4E-PB1 phosphorylation by activating 
mTORC1, since not only MKK1/2 inhibitors, but also rapamycin, 
without inhibiting Erk1/2 activation, inhibits 4E-BP1 phosphoryla-
tion in LPS-stimulated Wt BMDM. Dissociation of phosphorylated 
4E-BP from the eIF4E–4E-BP complex allows the formation of the 
active eIF4F that facilitates the initiation of translation by its binding 
FIGURE 5: Cot/tpl2 regulates polysomal recruitment of eEF1α and eEF2 mRNA in LPS-
stimulated BMDM. Cell lysates of Wt and Cot/tpl2 BMDM stimulated for 3 h or not with LPS 
(300 ng/ml) were subjected to sucrose gradient, and different RNA fractions were pooled. 
The RNA isolated from the different RNA fractions was subjected to Northern blot or 
qRT-PCR analysis. (A) Three mRNA fractions from the sucrose gradient were isolated: 
nontranslated mRNA (nonpolysomal components, consisting of nonpolysomal mRNAs and 
nontranslating free 40S and 60S ribosomal; NP), moderately translated mRNA (LMP), and 
actively translated mRNA (HMP). These mRNA fractions were subjected to Northern blot 
analysis. The eEF1α and β-actin mRNA expression in the NP, LMP, and HMP fractions of 
nonstimulated and 3-h LPS-stimulated Wt and Cot/tpl2 KO BMDM is shown. Right, graphs 
represent the means ± SD from five independent experiments of the quantification of the 
LMP/NP and HMP/NP eEF1α and β-actin mRNA ratios in the different cell conditions. 
(B) eEF1α, β-actin, and eEF2 mRNA expression in the nonpolysomal and polysomal fractions 
analyzed by qRT-PCR. Graphs represent the means ± SD from five independent experiments 
of the quantification of the polysome/nonpolysome mRNA ratio in the different cell 
conditions.
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damage, and the control of inflammatory 
mediators at the level of translation 
has emerged as a key step in adjusting the 
magnitude of the response (reviewed in 
Anderson, 2008; Thomson et al., 2009; 
Mazumder et al., 2010).
Cot/tpl2 has emerged as an interesting 
new anti-inflammatory target by its capacity 
to activate Erk1/2, without involving the 
RAF proteins, during the innate immune re-
sponse. Here we show that Cot/tpl2 con-
trols mRNA stability and cap-dependent 
mRNA translation in the context of the in-
nate immune response generated upon the 
stimulation of macrophages by LPS, modu-
lating at the posttranscriptional level the 
production of inflammatory mediators in-
volved in the host response.
MATERIALS AND METHODS
Mice, BMDM preparation, and 
stimulation
C57BL/6J wild type and C57BL/6J Cot/tpl2 
KO animals were produced from hetero-
zygous mice (Cot/tpl2 KO+/− × Cot/tpl2 
KO+/−), and C57BL/6J Cot/tpl2 KD animals 
were produced from heterozygous C57BL/6J 
Cot/tpl2 KD+/− mice. All animals received 
care according to methods approved under 
institutional guidelines for the care and use 
of laboratory animals in research. BMDM 
were obtained as previously described 
(Lopez-Pelaez et al., 2011), and cells were 
then stimulated with LPS (Salmonella typh-
imurium; L726; Sigma-Aldrich, St. Louis, 
MO), poly I:C (Invitrogen, Carlsbad, CA), 
zymosan (Invitrogen), or IL-10 (PeproTech, Rocky Hill, NJ). Actino-
mycin D was purchased from Sigma-Aldrich and UO 126 from Tocris 
Bioscience (Ellisville, MO). PD 0325901 and rapamycin were gifts 
from, respectively, Philip Cohen (Dundee, Scotland) and Victor Calvo 
(Madrid, Spain).
Western blot analysis
Cell extracts were examined by Western blot as previously described 
(Rodriguez et al., 2008), using primary antibodies raised against the 
following proteins: from Santa Cruz Biotechnology (Santa Cruz, CA), 
Cot/tpl2, Erk2, P-T389 S6K1, RSK, S6K1, and SGK1; from Cell Sig-
naling Beverly, MA), P-T202/Y204 Erk1/2, P-S473 Akt, P-T308 Akt, 
Akt, P-T24 FOXO1, FOXO1, P-S939 TSC2, TSC2, β-actin, P-T573 
RSK, P-S235/236 S6, P-S366 eEF2k, eEF2k, P-S65 4E-BP1, 4E-BP1, 
P-S209 eIF4E, and eIF4E; and from Pierce Thermo Fisher Scientific 
(Rockford, IL), P-S1798 TSC2. Western blot analysis using P-S422 
SGK1 (sc-16745R; Santa Cruz Biotechnology) was performed as de-
scribed previously (Garcia-Martinez and Alessi, 2008). The second-
ary antibodies used were raised against rabbit (Cell Signaling), goat 
(Dako, Glostrup, Denmark), and mouse (Amersham, GE Healthcare 
Bio-Sciences, Piscataway, NJ).
7-Methyl-GTP pull-down assays
BMDM were washed twice in ice-cold phosphate-buffered saline, 
lysed in lysis/binding buffer (10 mM Tris-HCl, pH 8, 150 mM NaCl, 
1.5 mM MgCl2, 1 mM dithiothreitol [DTT], 0.2% NP-40, 1 U/ml 
rate of gene transcription and the stability of the mRNA itself. Our 
data here demonstrate that the increase in the total mRNA levels by 
Cot/tpl2 after LPS stimulation correlates with the induction in their 
mRNA stability induced by Cot/tpl2. All three TNFα, IL-6, and KC 
mRNAs contain AU-rich elements in the 3′ UTR, which are determi-
nant for modulating their half-life in the context of inflammation (re-
viewed in Anderson, 2008; Mazumder et al., 2010). In this context it 
was reported that Cot/tpl2 modulates cytoplasmic TNFα mRNA ex-
pression by a mechanism that targets the AU-rich element in the 3′ 
UTR of the TNF-α mRNA upon LPS stimulation (Dumitru et al., 2000). 
Indeed, MAPKAP-2, as well as MNK1 and 2, downstream kinases of 
Erk1/2 (Roux and Blenis, 2004), phosphorylate and inhibit hnRP40 
activity an AU-rich sequence-specific RNA-binding protein that de-
stabilizes TNFα mRNA (Rousseau et al., 2002; Buxade et al., 2005).
Translational control offers a strategic advantage because the 
use of the preexisting mRNAs bypasses lengthy nuclear control 
mechanisms (e.g., transcription, splicing, and transport). At the 
same time, it provides reversibility through modifications of reg-
ulatory intermediates, mainly via reversible phosphorylation, and 
provides macrophages with required rapid and accurate response 
capacity. Innate immune system cells are the first line of defense 
against pathogen infection, and fine control of the translation 
levels of inflammatory mediators by these cells is a crucial re-
quirement for the proper development of innate immune re-
sponse. Indeed, the host response against infection is a double-
edged sword, as an uncontrolled response can exacerbate tissue 
FIGURE 6: Cot/tpl2 controls TNFα, KC, and IL-6 production and polysomal recruitment of their 
mRNAs in LPS-stimulated BMDM. (A) The concentration of TNFα, IL-6, and KC in the 
supernatant of Wt and Cot/tpl2 KO BMDM stimulated or not for 3 or 8 h with LPS (300 ng/ml) 
was determined using a Luminex 100 system (Upstate, Millipore, Billerica, MA), according to the 
manufacturer’s instructions. Graphs show the means ± SD from three independent experiments. 
(B) TNFα, KC, and IL-6 mRNA expression in the nonpolysomal and polysomal RNA fractions 
described in Figure 5B was analyzed by qRT-PCR. Graphs represent the means ± SD from five 
independent experiments of the quantification of the polysome/nonpolysome mRNA ratio in 
the different cell conditions.
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according to the manufacturer’s instructions. 
Four hours after transfection, cells were 
washed with RPMI plus 0.5% fetal bovine 
serum (FBS) and incubated overnight in 
RPMI, 0.5% FBS, and gentamicin (80 μg/ml). 
Subsequently, cells were stimulated with 
LPS (300 ng/ml) for 3 h, and the Renilla and 
Firefly luciferase activities were measured in 
the cell extracts according to the manufac-
turer’s instructions (Promega, Madison, WI).
Isolation of polyribosomal RNA 
and Northern blot analysis
BMDMs (5 × 106 cells) stimulated or not for 
3 h with LPS (300 ng/ml) were washed 
twice on ice with hypotonic buffer (5 mM 
Tris-HCl, pH 7.5, 1.5 mM KCl, 2.5 mM 
MgCl2), lysed in lysis buffer (hypotonic buf-
fer plus 0.5% Triton X-100, 0.5% Na deoxy-
cholate, 120 U/ml of RNase inhibitor, and 
3 mM DTT), and centrifuged at 6000 rpm 
for 8 min at 4ºC. After measurement of 
protein concentration, heparin (1 mg/ml) 
was added to the extracts. Extract were 
loaded on a linear sucrose gradient (0.5 
and 1.5 M sucrose in 20 mM Tris-HCl, pH 8, 
80 mM NaCl, 5 mM MgCl2, and 1 mM DTT) 
and centrifuged in a Beckman SW41 rotor 
at 36,000 rpm for 2 h at 4ºC. Gradients 
were fractionated, following the RNA ab-
sorbance profile at 254 nm, in different 
fractions. Once collected, fractions were 
incubated with proteinase K (5 μg/ml) in 
proteinase K buffer (100 mM Tris-HCl, pH 
7.5, 50 mM EDTA, 5% SDS) for 30 min at 
37ºC. RNA for Northern blot analysis was 
isolated using phenol/chloroform, and hy-
bridization of Northern blots with the 
eEF1α and β-actin probes was performed 
as described previously (Shima et al., 
1998).
qRT-PCR
Total RNA was isolated from BMDMs (5 × 
106 cells) stimulated or not for 3 h with LPS 
(300 ng/ml), using the miRNeasy Mini Kit and according to the man-
ufacturer’s instructions (Qiagen, Valencia, CA). Recruited mRNA to 
polysomes was isolated using phenol/chloroform and further puri-
fied as described previously (del Prete et al., 2007). Briefly, RNA was 
subjected to a precipitation with 2 M LiCl at −20ºC overnight. After 
centrifugation (12,000 × g, 15 min at 4°C), pellets were washed 
twice with 70% ETOH (prestored at −20°C), air-dried, and resus-
pended in RNase-free water. qRT-PCR was performed as described 
previously (Rodriguez et al., 2008). The specific TAQMAN primers 
(Applied Biosystems, Foster City, CA) TNFα, IL-6, KC, β-actin, and 
18Sr were used.
Statistical analysis
Experiments shown were performed at least three times. The graph-
ical data presented, as the means ± SD, were analyzed with Student’s 
t test. Values were taken to be statistically significant at p < 0.05 
(*p < 0.05, **p < 0.01, ***p < 0.001).
RNase OUT [Invitrogen], 1 mM phenylmethylsulfonyl fluoride, plus 1 
tablet/50 ml of Roche [Indianapolis, IN] inhibitors) and centrifuged 
at 1400 rpm for 15 min at 4ºC. One milligram of supernatant protein 
was added to 50 μl of 7-methyl GTP (m7GTP) Sepharose (Amer-
sham), previously precleared with washing buffer (10 mM Tris-HCl, 
pH 8, 150 mM NaCl, 1.5 mM MgCl2). Samples were tumbled at 4°C 
overnight and, after five washes in 1 ml of washing buffer plus 1 mM 
DTT, were boiled in Laemmli sample buffer and separated on 7–15% 
SDS–PAGE gels. Western blot analysis was performed to determine 
coprecipitated 4E-BP1 and eIF4E proteins.
BMDM nucleofection
BMDM were nucleofected with the biscitronic pcDNA3rLuc-polI-
RESfLuc plasmid (1 μg/1 × 106 cells), generously provided by Alexey 
Benyumov (University of Minnesota) using the Ingenio Electropora-
tion Kit (Mirus Bio, Madison, WI) and the Nucleofector System 
(Amaxa Biosystems, Lonza, Cologne, Germany) and performed 
FIGURE 7: Cot/tpl2 controls TNFα, KC, and IL-6 mRNA stability in LPS-stimulated BMDM. 
(A) Total RNA from Wt and Cot/tpl2 KO BMDM stimulated or not for 3 h with LPS (300 ng/ml) 
was extracted, and TNFα, KC, and IL-6 mRNA expression was determined by qRT-PCR analysis. 
TNFα, KC, and IL-6 expression levels were normalized to levels of 18Sr mRNA expression in 
each assay. Graphs show the mean ± SD from five independent experiments, giving the value of 
1 to the one obtained in control Wt BMDM. (B) The stability of TNFα, KC, IL-6, and β-actin 
mRNA in 3-h LPS-stimulated Wt and Cot/tpl2 KO BMDM was determined. Wt and Cot/tpl2 KO 
BMDM were stimulated for 3 h with LPS (300 ng/ml), and then actinomycin D (5 μg/ml) was 
added. At the indicated times cells were lysed, and subsequently the TNFα, IL-6, KC, and β-actin 
mRNA levels were analyzed by qRT-PCR and normalized by the expression of 18Sr mRNA. 
Graphs shown the means ± SD from three independent experiments, giving the value of 100% 
to the normalized mRNA levels obtained for Wt BMDM 3 h after the LPS stimulation.
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